|
|
Volumn 25, Issue 9, 2000, Pages 621-676
|
|
Adverse cardiovascular drug interactions.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CARDIOTONIC AGENT;
CARDIOVASCULAR AGENT;
FIBRINOLYTIC AGENT;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE;
VASODILATOR AGENT;
DRUG CONTRAINDICATION;
DRUG EFFECT;
DRUG INTERACTION;
HEART;
HEART DISEASE;
HUMAN;
LIVER;
REVIEW;
ADRENERGIC BETA-ANTAGONISTS;
ANTI-ARRHYTHMIA AGENTS;
CALCIUM CHANNEL BLOCKERS;
CARDIOTONIC AGENTS;
CARDIOVASCULAR AGENTS;
DRUG INTERACTIONS;
FIBRINOLYTIC AGENTS;
HEART;
HEART DISEASES;
HUMANS;
HYDROXYMETHYLGLUTARYL COA REDUCTASES;
LIVER;
VASODILATOR AGENTS;
|
|
EID: 0034277176
PISSN: 01462806
EISSN: None
Source Type: Journal
DOI: 10.1067/mcd.2000.109090 Document Type: Article |
|
Times cited : (11)
|
|
References (176)
|
